Concepedia

Lloyd E. Damon

LE

65

Publications

6.6K

Citations

35

H-Index

1991

Active since

Affiliations

University of California, San Francisco(Current)

UCSF Helen Diller Family Comprehensive Cancer Center

The University of Texas MD Anderson Cancer Center

Memorial Sloan Kettering Cancer Center

Johns Hopkins University

Lloyd E. Damon is an author at University of California, San Francisco specializing in medicine, hematology, and oncology.

ORCID

Top concepts

Publications per year

1991–2021

65

Publications

65

Acute myeloid leukemia ontogeny is defined by distinct somatic mutations

R. Coleman Lindsley, Brenton G. Mar, Emanuele Mazzola et al. · Blood · 2014 · 960 citations · Full text

Long-term clinical outcomes of tisagenlecleucel in patients with relapsed or refractory aggressive B-cell lymphomas (JULIET): a multicentre, open-label, single-arm, phase 2 study

Stephen J. Schuster, Constantine S. Tam, Peter Borchmann et al. · The Lancet Oncology · 2021 · 528 citations

, , +8

Rituximab therapy for CNS lymphomas: targeting the leptomeningeal compartment

James L. Rubenstein, Dan Combs, J. Rosenberg et al. · Blood · 2002 · 419 citations · Full text

Phase 2 trial of CPX-351, a fixed 5:1 molar ratio of cytarabine/daunorubicin, vs cytarabine/daunorubicin in older adults with untreated AML

Jeffrey E. Lancet, Jörge E. Cortes, Donna E. Hogge et al. · Blood · 2014 · 334 citations · Full text

Phase I Study of Intraventricular Administration of Rituximab in Patients With Recurrent CNS and Intraocular Lymphoma

James L. Rubenstein, Jane Fridlyand, Lauren E. Abrey et al. · Journal of Clinical Oncology · 2007 · 323 citations · Full text

Rows per page

1–5 of 65